Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
K
217730
vs
K
KOSPI 200
Over the past 12 months, Kang Stem Biotech Co Ltd has underperformed KOSPI 200, delivering a return of +34% compared to KOSPI 200's +56% growth.
Stocks Performance
217730 vs KOSPI 200
Performance Gap
217730 vs KOSPI 200
Performance By Year
217730 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Kang Stem Biotech Co Ltd
Glance View
Kang Stem Biotech is a South Korean biotech company built around stem cell and cell-culture technology. It develops and sells products and services linked to stem cell research and medical use, and it also has ties to the skin-care and cosmetic side of the market where cell-based ingredients and treatments are sold. Its customers are mainly hospitals, clinics, research groups, and other businesses that need stem cell-related materials or want to use the company’s technology in their own products. The company makes money by selling these products, by charging for related services, and by working with partners that use its know-how in medical or commercial applications. What makes the business different is that it sits at the meeting point of biotech and aesthetic medicine. Instead of making broad consumer products like a typical drugmaker, it focuses on specialized cell technology and the downstream products that can be built from it, which gives it a niche role in a small, technical part of the healthcare and beauty value chain.